PubMed

Association of Circulating Cholesteryl Ester Transfer Protein Activity With Incidence of Cardiovascular Disease in the Community.

Vasan RS, Pencina MJ, Robins SJ, Zachariah JP, Kaur G, D'Agostino RB, Ordovas JM.

Circulation. 2009 Nov 30. [Epub ahead of print]PMID: 19948972 [PubMed - as supplied by publisher]

Relations of Lipid Concentrations to Heart Failure Incidence. The Framingham Heart Study.

Velagaleti RS, Massaro J, Vasan RS, Robins SJ, Kannel WB, Levy D.

Circulation. 2009 Nov 23. [Epub ahead of print]PMID: 19933936 [PubMed - as supplied by publisher]

Morbidity and Mortality Risk Among the "Forgotten Few": Why Are Girls in the Justice System in Such Poor Health?

Odgers CL, Robins SJ, Russell MA.

Law Hum Behav. 2009 Oct 22. [Epub ahead of print]PMID: 19847634 [PubMed - as supplied by publisher]Related articles

Adiposity, Cardiometabolic Risk, and Vitamin D Status: the Framingham Heart Study.

Cheng S, Massaro JM, Fox CS, Larson MG, Keyes MJ, McCabe EL, Robins SJ, O'Donnell CJ, Hoffmann U, Jacques PF, Booth SL, Vasan RS, Wolf M, Wang TJ.

Diabetes. 2009 Oct 15. [Epub ahead of print]PMID: 19833894 [PubMed - as supplied by publisher]Related articles

Contemporary trends in dyslipidemia in the Framingham Heart Study.

Ingelsson E, Massaro JM, Sutherland P, Jacques PF, Levy D, D'Agostino RB, Vasan RS, Robins SJ.

Arch Intern Med. 2009 Feb 9;169(3):279-86.PMID: 19204219 [PubMed - indexed for MEDLINE]Related articles

Clinical and genetic factors associated with lipoprotein-associated phospholipase A2 in the Framingham Heart Study.

Schnabel R, Dupuis J, Larson MG, Lunetta KL, Robins SJ, Zhu Y, Rong J, Yin X, Stirnadel HA, Nelson JJ, Wilson PW, Keaney JF, Vasan RS, Benjamin EJ.

Atherosclerosis. 2009 Jun;204(2):601-7. Epub 2008 Nov 5.PMID: 19135199 [PubMed - indexed for MEDLINE]Related articles

Long-term C-reactive protein variability and prediction of metabolic risk.

Chen TH, Gona P, Sutherland PA, Benjamin EJ, Wilson PW, Larson MG, Vasan RS, Robins SJ.

Am J Med. 2009 Jan;122(1):53-61.PMID: 19114172 [PubMed - indexed for MEDLINE]Related articles

Clinical correlates and heritability of cystatin C (from the Framingham Offspring Study).

Parikh NI, Hwang SJ, Yang Q, Larson MG, Guo CY, Robins SJ, Sutherland P, Benjamin EJ, Levy D, Fox CS.

Am J Cardiol. 2008 Nov 1;102(9):1194-8. Epub 2008 Sep 12.PMID: 18940290 [PubMed - indexed for MEDLINE]Related articlesFree article

Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.

Robins SJ, Collins D, Nelson JJ, Bloomfield HE, Asztalos BF.

Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1172-8. Epub 2008 Mar 20.PMID: 18356553 [PubMed - indexed for MEDLINE]Related articlesFree article

Usefulness of the triglyceride-high-density lipoprotein versus the cholesterol-high-density lipoprotein ratio for predicting insulin resistance and cardiometabolic risk (from the Framingham Offspring Cohort).

Kannel WB, Vasan RS, Keyes MJ, Sullivan LM, Robins SJ.

Am J Cardiol. 2008 Feb 15;101(4):497-501.PMID: 18312765 [PubMed - indexed for MEDLINE]Related articles

Relation of gemfibrozil treatment and high-density lipoprotein subpopulation profile with cardiovascular events in the Veterans Affairs High-Density Lipoprotein Intervention Trial.

Asztalos BF, Collins D, Horvath KV, Bloomfield HE, Robins SJ, Schaefer EJ.

Metabolism. 2008 Jan;57(1):77-83.PMID: 18078862 [PubMed - indexed for MEDLINE]Related articlesFree article

Genome-wide association with select biomarker traits in the Framingham Heart Study.

Benjamin EJ, Dupuis J, Larson MG, Lunetta KL, Booth SL, Govindaraju DR, Kathiresan S, Keaney JF Jr, Keyes MJ, Lin JP, Meigs JB, Robins SJ, Rong J, Schnabel R, Vita JA, Wang TJ, Wilson PW, Wolf PA, Vasan RS.

BMC Med Genet. 2007 Sep 19;8 Suppl 1:S11.PMID: 17903293 [PubMed - indexed for MEDLINE]Related articlesFree article

Body weight, plasma insulin, and coronary events with gemfibrozil in the Veterans Affairs High-Density Lipoprotein Intervention Trial (VA-HIT).

Robins SJ, Collins D, McNamara JR, Bloomfield HE.

Atherosclerosis. 2008 Feb;196(2):849-55. Epub 2007 Mar 1.PMID: 17335828 [PubMed - indexed for MEDLINE]Related articles

Multiple biomarkers and the risk of incident hypertension.

Wang TJ, Gona P, Larson MG, Levy D, Benjamin EJ, Tofler GH, Jacques PF, Meigs JB, Rifai N, Selhub J, Robins SJ, Newton-Cheh C, Vasan RS.

Hypertension. 2007 Mar;49(3):432-8. Epub 2007 Jan 22.PMID: 17242302 [PubMed - indexed for MEDLINE]Related articlesFree article

Multiple biomarkers for the prediction of first major cardiovascular events and death.

Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, Jacques PF, Rifai N, Selhub J, Robins SJ, Benjamin EJ, D'Agostino RB, Vasan RS.

N Engl J Med. 2006 Dec 21;355(25):2631-9.PMID: 17182988 [PubMed - indexed for MEDLINE]Related articlesFree article

Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study.

Schaefer EJ, Bongard V, Beiser AS, Lamon-Fava S, Robins SJ, Au R, Tucker KL, Kyle DJ, Wilson PW, Wolf PA.

Arch Neurol. 2006 Nov;63(11):1545-50.PMID: 17101822 [PubMed - indexed for MEDLINE]Related articlesFree article

Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.

Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, Wang TJ, Benjamin EJ, D'Agostino RB, Vasan RS.

Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):127-33. Epub 2006 Nov 9.PMID: 17095717 [PubMed - indexed for MEDLINE]Related articlesFree article

Codon 54 polymorphism of the fatty acid binding protein (FABP) 2 gene is associated with increased cardiovascular risk in the dyslipidemic diabetic participants of the Veterans Affairs HDL intervention trial (VA-HIT).

Georgopoulos A, Bloomfield H, Collins D, Brousseau ME, Ordovas JM, O'Connor JJ, Robins SJ, Schaefer EJ.

Atherosclerosis. 2007 Sep;194(1):169-74. Epub 2006 Aug 30.PMID: 16945373 [PubMed - indexed for MEDLINE]Related articles

Fibric acid derivatives in cardiovascular disease prevention: results from the large clinical trials.

Robins SJ, Bloomfield HE.

Curr Opin Lipidol. 2006 Aug;17(4):431-9. Review.PMID: 16832168 [PubMed - indexed for MEDLINE]Related articles

Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.

Otvos JD, Collins D, Freedman DS, Shalaurova I, Schaefer EJ, McNamara JR, Bloomfield HE, Robins SJ.

Circulation. 2006 Mar 28;113(12):1556-63. Epub 2006 Mar 13.PMID: 16534013 [PubMed - indexed for MEDLINE]Related articlesFree article

Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study.

Kathiresan S, Otvos JD, Sullivan LM, Keyes MJ, Schaefer EJ, Wilson PW, D'Agostino RB, Vasan RS, Robins SJ.

Circulation. 2006 Jan 3;113(1):20-9. Epub 2005 Dec 27.PMID: 16380547 [PubMed - indexed for MEDLINE]Related articlesFree article

LpA-I, LpA-I:A-II HDL and CHD-risk: The Framingham Offspring Study and the Veterans Affairs HDL Intervention Trial.

Asztalos BF, Demissie S, Cupples LA, Collins D, Cox CE, Horvath KV, Bloomfield HE, Robins SJ, Schaefer EJ.

Atherosclerosis. 2006 Sep;188(1):59-67. Epub 2005 Nov 18.PMID: 16298372 [PubMed - indexed for MEDLINE]Related articles

Lipid therapy for cardiovascular disease with insulin resistance, diabetes, or the metabolic syndrome.

Robins SJ.

Curr Cardiol Rep. 2005 Nov;7(6):457-64. Review.PMID: 16256016 [PubMed - indexed for MEDLINE]Related articles

The L162V polymorphism at the peroxisome proliferator activated receptor alpha locus modulates the risk of cardiovascular events associated with insulin resistance and diabetes mellitus: the Veterans Affairs HDL Intervention Trial (VA-HIT).

Tai ES, Collins D, Robins SJ, O'Connor JJ Jr, Bloomfield HE, Ordovas JM, Schaefer EJ, Brousseau ME.

Atherosclerosis. 2006 Jul;187(1):153-60. Epub 2005 Oct 10.PMID: 16221474 [PubMed - indexed for MEDLINE]Related articles

Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial.

Asztalos BF, Collins D, Cupples LA, Demissie S, Horvath KV, Bloomfield HE, Robins SJ, Schaefer EJ.

Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2185-91. Epub 2005 Aug 25.PMID: 16123324 [PubMed - indexed for MEDLINE]Related articlesFree article

Role of fibric acid derivatives in the management of risk factors for coronary heart disease.

Després JP, Lemieux I, Robins SJ.

Drugs. 2004;64(19):2177-98. Review.PMID: 15456334 [PubMed - indexed for MEDLINE]Related articles

Polymorphisms in the gene encoding lipoprotein lipase in men with low HDL-C and coronary heart disease: the Veterans Affairs HDL Intervention Trial.

Brousseau ME, Goldkamp AL, Collins D, Demissie S, Connolly AC, Cupples LA, Ordovas JM, Bloomfield HE, Robins SJ, Schaefer EJ.

J Lipid Res. 2004 Oct;45(10):1885-91. Epub 2004 Aug 1.PMID: 15292370 [PubMed - indexed for MEDLINE]Related articlesFree article

Cardiovascular disease with diabetes or the metabolic syndrome: should statins or fibrates be first line lipid therapy?

Robins SJ.

Curr Opin Lipidol. 2003 Dec;14(6):575-83. Review.PMID: 14624134 [PubMed - indexed for MEDLINE]Related articles

Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT).

Robins SJ, Rubins HB, Faas FH, Schaefer EJ, Elam MB, Anderson JW, Collins D; Veterans Affairs HDL Intervention Trial (VA-HIT).

Diabetes Care. 2003 May;26(5):1513-7.PMID: 12716814 [PubMed - indexed for MEDLINE]Related articlesFree article

MRC/BHF Heart Protection Study.

Robins SJ, Despres JP; MRC/BHF Heart Protection Study.

Lancet. 2002 Nov 30;360(9347):1780; author reply 1783-4. No abstract available. PMID: 12480447 [PubMed - indexed for MEDLINE]Related articles

Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT).

Rubins HB, Robins SJ, Collins D, Nelson DB, Elam MB, Schaefer EJ, Faas FH, Anderson JW.

Arch Intern Med. 2002 Dec 9-23;162(22):2597-604.PMID: 12456232 [PubMed - indexed for MEDLINE]Related articlesFree article

Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial.

Brousseau ME, O'Connor JJ Jr, Ordovas JM, Collins D, Otvos JD, Massov T, McNamara JR, Rubins HB, Robins SJ, Schaefer EJ.

Arterioscler Thromb Vasc Biol. 2002 Jul 1;22(7):1148-54.PMID: 12117730 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of lipid disorders after stroke.

Gomes JA, Robins SJ, Babikian VL.

Curr Atheroscler Rep. 2002 Jul;4(4):304-10. Review.PMID: 12052282 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of gemfibrozil for coronary heart disease patients with low levels of high-density lipoprotein cholesterol: the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial.

Nyman JA, Martinson MS, Nelson D, Nugent S, Collins D, Wittes J, Fye CL, Wilt TJ, Robins SJ, Bloomfield Rubins H; VA-HIT Study Group.

Arch Intern Med. 2002 Jan 28;162(2):177-82.PMID: 11802751 [PubMed - indexed for MEDLINE]Related articlesFree article

Targeting low high-density lipoprotein cholesterol for therapy: lessons from the Veterans Affairs High-density Lipoprotein Intervention Trial.

Robins SJ.

Am J Cardiol. 2001 Dec 20;88(12A):19N-23N. Review.PMID: 11788126 [PubMed - indexed for MEDLINE]Related articles

PPARalpha ligands and clinical trials: cardiovascular risk reduction with fibrates.

Robins SJ.

J Cardiovasc Risk. 2001 Aug;8(4):195-201. Review. No abstract available. PMID: 11550997 [PubMed - indexed for MEDLINE]Related articles

Safety and tolerability of esterified phytosterols administered in reduced-fat spread and salad dressing to healthy adult men and women.

Davidson MH, Maki KC, Umporowicz DM, Ingram KA, Dicklin MR, Schaefer E, Lane RW, McNamara JR, Ribaya-Mercado JD, Perrone G, Robins SJ, Franke WC.

J Am Coll Nutr. 2001 Aug;20(4):307-19.PMID: 11506058 [PubMed - indexed for MEDLINE]Related articlesFree article

Lipid responses to plant-sterol-enriched reduced-fat spreads incorporated into a National Cholesterol Education Program Step I diet.

Maki KC, Davidson MH, Umporowicz DM, Schaefer EJ, Dicklin MR, Ingram KA, Chen S, McNamara JR, Gebhart BW, Ribaya-Mercado JD, Perrone G, Robins SJ, Franke WC.

Am J Clin Nutr. 2001 Jul;74(1):33-43.PMID: 11451715 [PubMed - indexed for MEDLINE]Related articlesFree article

Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT).

Bloomfield Rubins H, Davenport J, Babikian V, Brass LM, Collins D, Wexler L, Wagner S, Papademetriou V, Rutan G, Robins SJ; VA-HIT Study Group.

Circulation. 2001 Jun 12;103(23):2828-33.PMID: 11401940 [PubMed - indexed for MEDLINE]Related articlesFree article

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial.

Robins SJ, Collins D, Wittes JT, Papademetriou V, Deedwania PC, Schaefer EJ, McNamara JR, Kashyap ML, Hershman JM, Wexler LF, Rubins HB; VA-HIT Study Group. Veterans Affairs High-Density Lipoprotein Intervention Trial.

JAMA. 2001 Mar 28;285(12):1585-91.PMID: 11268266 [PubMed - indexed for MEDLINE]Related articlesFree article

Common variants in the gene encoding ATP-binding cassette transporter 1 in men with low HDL cholesterol levels and coronary heart disease.

Brousseau ME, Bodzioch M, Schaefer EJ, Goldkamp AL, Kielar D, Probst M, Ordovas JM, Aslanidis C, Lackner KJ, Bloomfield Rubins H, Collins D, Robins SJ, Wilson PW, Schmitz G.

Atherosclerosis. 2001 Feb 15;154(3):607-11.PMID: 11257261 [PubMed - indexed for MEDLINE]Related articles

Effect of ursodeoxycholic acid on hepatic LDL binding and uptake in dietary hypercholesterolemic hamsters.

Ceryak S, Bouscarel B, Malavolti M, Robins SJ, Caslow KL, Fromm H.

Atherosclerosis. 2000 Nov;153(1):59-67.PMID: 11058700 [PubMed - indexed for MEDLINE]Related articles

Conclusions from the VA-HIT study.

Rubins HB, Robins SJ.

Am J Cardiol. 2000 Sep 1;86(5):543-4. No abstract available. PMID: 11009274 [PubMed - indexed for MEDLINE]Related articles

The VA HDL intervention trial: clinical implications.

Rubins HB, Collins D, Robins SJ.

Eur Heart J. 2000 Jul;21(14):1113-5. Review. No abstract available. PMID: 10924289 [PubMed - indexed for MEDLINE]Related articlesFree article

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.

Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, Faas FH, Linares E, Schaefer EJ, Schectman G, Wilt TJ, Wittes J.

N Engl J Med. 1999 Aug 5;341(6):410-8.PMID: 10438259 [PubMed - indexed for MEDLINE]Related articlesFree article

Delineation of a novel hepatic route for the selective transfer of unesterified sterols from high-density lipoproteins to bile: studies using the perfused rat liver.

Robins SJ, Fasulo JM.

Hepatology. 1999 May;29(5):1541-8.PMID: 10216140 [PubMed - indexed for MEDLINE]Related articles

Separation and quantitation of phospholipid classes by HPLC.

Patton GM, Robins SJ.

Methods Mol Biol. 1998;110:193-215. Review. No abstract available. PMID: 9918048 [PubMed - indexed for MEDLINE]Related articles

Carotid atherosclerosis in men with low levels of HDL cholesterol.

Wilt TJ, Rubins HB, Robins SJ, Riley WA, Collins D, Elam M, Rutan G, Anderson JW.

Stroke. 1997 Oct;28(10):1919-25.PMID: 9341696 [PubMed - indexed for MEDLINE]Related articlesFree article

High density lipoproteins, but not other lipoproteins, provide a vehicle for sterol transport to bile.

Robins SJ, Fasulo JM.

J Clin Invest. 1997 Feb 1;99(3):380-4.PMID: 9022069 [PubMed - indexed for MEDLINE]Related articlesFree article

The Veterans Affairs High-Density Lipoprotein Intervention Trial: baseline characteristics of normocholesterolemic men with coronary artery disease and low levels of high-density lipoprotein cholesterol. Veterans Affairs Cooperative Studies Program High-Density Lipoprotein Intervention Trial Study Group.

Rubins HB, Robins SJ, Collins D.

Am J Cardiol. 1996 Sep 1;78(5):572-5.PMID: 8806347 [PubMed - indexed for MEDLINE]Related articles